Concentra Group CON 深 沪
等待开盘 09-24 09:30:00 美东时间
34.79
-0.090
-0.26%
华盛通- 最 高35.22
- 今 开34.85
- 成交量 81.54万股
- 最 低 34.545
- 昨 收 34.88
- 总市值 44.36亿
- 52周最高 36.71
- 市盈率 静 27.19
- 换手率 0.64%
- 52周最低 18.295
- 委 比 50.00%
- 总股本 1.28亿
- 历史最高 36.71
- 量 比 0.48
- 振 幅 1.94%
- 历史最低 18.295
- 每 手 1
- 风险率 5.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 齐声看好医药股！礼来、强生、默沙东目标价均获上调；小摩大幅上调Meta目标价至820美元
今日重点评级关注：康托·菲茨杰拉德：维持SOL Strategies"超配"评级，目标价从2.8美元升至6.2美元；康托·菲茨杰拉德：维持Sui Group Holdings"超配"评级，目标价从1.7美元升至3.4美元
09-11 14:30
JP Morgan Maintains Overweight on Concentra Group Holdings, Raises Price Target to $43
JP Morgan analyst Benjamin Rossi maintains Concentra Group Holdings (NYSE:CON) with a Overweight and raises the price target from $34 to $43.
09-10 22:25
Concentra Announces CFO Appointment Amid Leadership Succession
Concentra Group Holdings Parent, Inc. ( ($CON) ) just unveiled an update. Conce...
09-09 04:57
Concentra appoints Tanner Newton as CFO
Concentra (CON) announced on Tuesday that Tanner Newton, senior vice president of strategy and finance, has been appointed executive vice president and chief financial officer, effective Nov. 1, 2026....
09-08 21:37
Concentra Announces Insider Share Repurchase Agreement Completion
Concentra Group Holdings Parent, Inc. ( ($CON) ) has provided an announcement. ...
08-28 05:18
美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
Concentra Group Holdings shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.
Concentra Group Holdings shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.
08-07 23:09
Concentra Group Holdings Raises FY2026 Sales Guidance from $2.275B-$2.375B to $2.325B-$2.375B vs $2.334B Est
Concentra Group Holdings (NYSE:CON) raises FY2026 sales outlook from $2.275 billion-$2.375 billion to $2.325 billion-$2.375 billion vs $2.334 billion estimate.
08-07 04:39
Concentra Group Holdings Q2 Adj. EPS $0.51 Beats $0.42 Estimate, Sales $606.030M Beat $591.672M Estimate
Concentra Group Holdings (NYSE:CON) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.42 by 21.43 percent. This is a 37.84 percent increase over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $606.030 m...
08-07 04:38
